Effect of GFR on plasma N-terminal Connective Tissue Growth Factor (CTGF) concentrations

American Journal of Kidney Diseases

Volumn 59, Issue 5, 2012, Pages 619-627

  Gerritsen, Karin G ^a   Abrahams, Alferso C ^a   Peters, Hilde P ^b   Nguyen, Tri Q ^a   Koeners, Maarten P ^a   Den Hoedt, Claire H ^a,c   Dendooven, Amelie ^a   Van Den Dorpel, Marinus A ^c   Blankestijn, Peter J ^a   Wetzels, Jack F ^b   Joles, Jaap A ^a   Goldschmeding, Roel ^a   Kok, Robbert J ^d  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Maasstad Hospital Rotterdam   (Netherlands)

^d UTRECHT UNIVERSITY   (Netherlands)

Author keywords

CCN2; Connective tissue growth factor; glomerular filtration rate; middle molecule; uremic toxin

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; HEMODIAFILTRATION; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; KIDNEY CLEARANCE; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY GRAFT; LONGITUDINAL STUDY; MALE; NONHUMAN; OBSERVATIONAL STUDY; PLASMA; PROTEIN BLOOD LEVEL; RAT; RENAL REPLACEMENT THERAPY; RODENT;

ADULT; AGED; ANIMALS; CHRONIC DISEASE; CONNECTIVE TISSUE GROWTH FACTOR; CROSS-SECTIONAL STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; HEMODIAFILTRATION; HUMANS; KIDNEY; KIDNEY DISEASES; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MICE; MICE, INBRED C57BL; MIDDLE AGED; MODELS, ANIMAL; RATS; RATS, INBRED WKY; RENAL DIALYSIS;

EID: 84859798139     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2011.12.019     Document Type: Article

References (45)

1. Koitabashi N, Arai M, Kogure S, et al. Increased connective tissue growth factor relative to brain natriuretic peptide as a determinant of myocardial fibrosis. Hypertension. 2007;49(5):1120-1127. (Pubitemid 351664300)
2. Yoon PO, Lee MA, Cha H, et al. The opposing effects of CCN2 and CCN5 on the development of cardiac hypertrophy and fibrosis. J Mol Cell Cardiol. 2010;49(2):294-303.
3. Finckenberg P, Lassila M, Inkinen K, et al. Cyclosporine induces myocardial connective tissue growth factor in spontaneously hypertensive rats on high-sodium diet. Transplantation. 2001;71(7):951-958. (Pubitemid 32417358)
4. Ito Y, Aten J, Bende RJ, et al. Expression of connective tissue growth factor in human renal fibrosis. Kidney Int. 1998;53(4):853-861. (Pubitemid 28155657)
5. Turk T, Leeuwis JW, Gray J, et al. BMP signaling and podocyte markers are decreased in human diabetic nephropathy in association with CTGF overexpression. J Histochem Cytochem. 2009;57(7):623-631.
6. Guha M, Xu ZG, Tung D, Lanting L, Natarajan R. Specific down-regulation of connective tissue growth factor attenuates progression of nephropathy in mouse models of type 1 and type 2 diabetes. FASEB J. 2007;21(12):3355-3368. (Pubitemid 47565554)
7. Adler SG, Schwartz S, Williams ME, et al. Phase 1 study of anti-CTGF monoclonal antibody in patients with diabetes and microalbuminuria. Clin J Am Soc Nephrol. 2010;5(8):1420-1428.
8. Oemar BS, Werner A, Garnier JM, et al. Human connective tissue growth factor is expressed in advanced atherosclerotic lesions. Circulation. 1997;95(4):831-839. (Pubitemid 27091522)
9. Cicha I, Yilmaz A, Klein M, et al. Connective tissue growth factor is overexpressed in complicated atherosclerotic plaques and induces mononuclear cell chemotaxis in vitro. Arterioscler Thromb Vasc Biol. 2005;25(5):1008-1013. (Pubitemid 40627847)
10. Hishikawa K, Oemar BS, Tanner FC, Nakaki T, Fujii T, Luscher TF. Overexpression of connective tissue growth factor gene induces apoptosis in human aortic smooth muscle cells. Circulation. 1999;100(20):2108-2112. (Pubitemid 29532063)
11. Leeuwis JW, Nguyen TQ, Theunissen MG, et al. Connective tissue growth factor is associated with a stable atherosclerotic plaque phenotype and is involved in plaque stabilization after stroke. Stroke. 2010;41(12):2979-2981.
12. Roestenberg P, van Nieuwenhoven FA, Wieten L, et al. Connective tissue growth factor is increased in plasma of type 1 diabetic patients with nephropathy. Diabetes Care. 2004;27(5): 1164-1170. (Pubitemid 38579784)
13. Cheng O, Thuillier R, Sampson E, et al. Connective tissue growth factor is a biomarker and mediator of kidney allograft fibrosis. Am J Transplant. 2006;6(10):2292-2306. (Pubitemid 44359414)
14. Nguyen TQ, Tarnow L, Jorsal A, et al. Plasma connective tissue growth factor is an independent predictor of end-stage renal disease and mortality in type 1 diabetic nephropathy. Diabetes Care. 2008;31(6):1177-1182.
15. Ito Y, Aten J, Nguyen TQ, et al. Involvement of connective tissue growth factor in human and experimental hypertensive nephrosclerosis. Nephron Exp Nephrol. 2011;117(1):e9-e20.
16. Jaffa AA, Usinger WR, McHenry MB, et al. Connective tissue growth factor and susceptibility to renal and vascular disease risk in type 1 diabetes. J Clin Endocrinol Metab. 2008;93(5):1893-1900. (Pubitemid 351656535)
17. Koitabashi N, Arai M, Niwano K, et al. Plasma connective tissue growth factor is a novel potential biomarker of cardiac dysfunction in patients with chronic heart failure. Eur J Heart Fail. 2008;10(4):373-379.
18. Miyazaki O, Kurashita S, Fukamachi I, Endo K, Ng PS, Takehara K. Subtraction method for determination of N-terminal connective tissue growth factor. Ann Clin Biochem. 2010;47(pt 3):205-211.
19. Penne EL, van derWeerd NC, Blankestijn PJ, et al. Role of residual kidney function and convective volume on change in beta2-microglobulin levels in hemodiafiltration patients. Clin J Am Soc Nephrol. 2010;5(1):80-86.
20. Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145(4):247-254. (Pubitemid 46768608)
21. Fouque D, Vennegoor M, ter Wee P, et al. EBPG guideline on nutrition. Nephrol Dial Transplant. 2007;22(suppl 2):ii45-ii87.
22. Gerritsen KG, Peters HP, Nguyen TQ, et al. Renal proximal tubular dysfunction is a major determinant of urinary connective tissue growth factor excretion. Am J Physiol Renal Physiol. 2010; 298(6):F1457-F1464.
23. Dendooven A, Gerritsen KG, Nguyen TQ, Kok RJ, Goldschmeding R. Connective tissue growth factor (CTGF/CCN2) ELISA: a novel tool for monitoring fibrosis. Biomarkers. 2011;16(4):289-301.
24. Verseput GH, Provoost AP, Braam BB, Weening JJ, Koomans HA. Angiotensin-converting enzyme inhibition in the prevention and treatment of chronic renal damage in the hypertensive fawn-hooded rat. J Am Soc Nephrol. 1997;8(2):249-259. (Pubitemid 127455880)
25. Prakash J, Sandovici M, Saluja V, et al. Intracellular delivery of the p38 mitogen-activated protein kinase inhibitor SB202190 [4-(4-fluorophenyl)-2- (4-hydroxyphenyl)-5-(4-pyridyl)1H-imidazole] in renal tubular cells: a novel strategy to treat renal fibrosis. J Pharmacol Exp Ther. 2006;319(1):8-19. (Pubitemid 44455106)
26. Chapman ME, Hu L, Plato CF, Kohan DE. Bioimpedance spectroscopy for the estimation of body fluid volumes in mice. Am J Physiol Renal Physiol. 2010;299(1):F280-F283.
27. Qi Z, Whitt I, Mehta A, et al. Serial determination of glomerular filtration rate in conscious mice using FITC-inulin clearance. Am J Physiol Renal Physiol. 2004;286(3):F590-F596. (Pubitemid 38233654)
28. LornoyW, Becaus I, Billiouw JM, Sierens L, Van Malderen P, D'Haenens P. On-line haemodiafiltration. Remarkable removal of beta2-microglobulin. Long-term clinical observations. Nephrol Dial Transplant. 2000;15(suppl 1):49-54. (Pubitemid 30114210)
29. Owen WF Jr, Lew NL, Liu Y, Lowrie EG, Lazarus JM. The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med. 1993;329(14):1001-1006. (Pubitemid 23307908)
30. Maack T, Johnson V, Kau ST, Figueiredo J, Sigulem D. Renal filtration, transport, and metabolism of low-molecular-weight proteins: a review. Kidney Int. 1979;16(3):251-270. (Pubitemid 10208487)
31. Christensen EI, Moskaug JO, Vorum H, et al. Evidence for an essential role of megalin in transepithelial transport of retinol. J Am Soc Nephrol. 1999;10(4):685-695. (Pubitemid 29149517)
32. Pohl M, Kaminski H, Castrop H, et al. Intrarenal renin angiotensin system revisited: role of megalin-dependent endocytosis along the proximal nephron. J Biol Chem. 2010;285(53): 41935-41946.
33. Sarav M, Wang Y, Hack BK, et al. Renal FcRn reclaims albumin but facilitates elimination of IgG. J Am Soc Nephrol. 2009;20(9):1941-1952.
34. Christensen EI, Verroust PJ, Nielsen R. Receptor-mediated endocytosis in renal proximal tubule. Pflugers Arch. 2009;458(6): 1039-1048.
35. Viberti GC, Bilous RW, Mackintosh D, Keen H. Monitoring glomerular function in diabetic nephropathy. A prospective study. Am J Med. 1983;74(2):256-264. (Pubitemid 13192182)
36. Vincent C, Chanard J, Caudwell V, Lavaud S, Wong T, Revillard JP. Kinetics of 125I-beta 2-microglobulin turnover in dialyzed patients. Kidney Int. 1992;42(6):1434-1443.
37. Wang AY, Lai KN. The importance of residual renal function in dialysis patients. Kidney Int. 2006;69(10):1726-1732. (Pubitemid 43739198)
38. Vanholder R, De Smet R, Glorieux G, et al. Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int. 2003;63(5):1934-1943. (Pubitemid 36513344)
39. Panek AN, Posch MG, Alenina N, et al. Connective tissue growth factor overexpression in cardiomyocytes promotes cardiac hypertrophy and protection against pressure overload. PLoS One. 2009;4(8):e6743.
40. Cozzolino M, Biondi ML, Banfi E, et al. CCN2 (CTGF) gene polymorphism is a novel prognostic risk factor for cardiovascular outcomes in hemodialysis patients. Blood Purif. 2010;30(4): 272-276.
41. Andersen S, van Nieuwenhoven FA, Tarnow L, et al. Reduction of urinary connective tissue growth factor by losartan in type 1 patients with diabetic nephropathy. Kidney Int. 2005;67(6): 2325-2329. (Pubitemid 41623393)
42. Daniels A, van Bilsen M, Goldschmeding R, van der Vusse GJ, van Nieuwenhoven FA. Connective tissue growth factor and cardiac fibrosis. Acta Physiol (Oxf). 2009;195(3):321-338.
43. Grotendorst GR, Duncan MR. Individual domains of connective tissue growth factor regulate fibroblast proliferation and myofibroblast differentiation. FASEB J. 2005;19(7):729-738. (Pubitemid 40617377)
44. Flyvbjerg A, Khatir D, Jensen LJ, et al. Long-term renal effects of a neutralizing connective tissue growth factor (CTGF)-antibody in obese type 2 diabetic mice [abstract]. J Am Soc Nephrol. 2004;15:261.
45. Langsetmo I, Jacob CT, Zhang W, et al. Anti-CTGF human antibody FG-3019 prevents and reverses diabetes-induced cardiovascular complications in streptozotocin (STZ) treated rats [abstract]. Diabetes 2006;55(suppl 1):A122.